Presents CITIZEN GREEN TECHNOLOGIES CITIZEN GREEN TECHNOLOGIES - - PowerPoint PPT Presentation

presents citizen green technologies
SMART_READER_LITE
LIVE PREVIEW

Presents CITIZEN GREEN TECHNOLOGIES CITIZEN GREEN TECHNOLOGIES - - PowerPoint PPT Presentation

Presents CITIZEN GREEN TECHNOLOGIES CITIZEN GREEN TECHNOLOGIES Forward Looking Statements This Presentation (together with any supplements and any other information that may be furnished to prospective investors by Global Cannabis


slide-1
SLIDE 1

Presents…

slide-2
SLIDE 2

CITIZEN GREEN TECHNOLOGIES

slide-3
SLIDE 3

CITIZEN GREEN TECHNOLOGIES

This Presentation (together with any supplements and any other information that may be furnished to prospective investors by Global Cannabis Applications Corp. (“Global Cannabis” or “Global Cannabis Applications”) contains “forward-looking statements” or “forward-looking information” within the meaning of applicable securities laws (collectively “Forward-looking Information”). Forward-looking Information is generally identifiably the use of the words “believes”, “may”, “plans”, “will”, “anticipates”, “intends”, “budgets”, “could”, “estimates”, “expects”, “forecasts”, “projects” and similar expressions, and the negatives of such expressions. Forward-looking Information in this Presentation includes, but is not limited to, statements concerning economic trends, the size of the market, the timing and scope of Global Cannabis Applications capital expenditures, the anticipated use of proceeds, financial forecasts, and the proposed ownership allocation. Global Cannabis Applications has based this Forward-looking Information on factors and assumptions about future events and financial trends that it believe may affect its financial condition, results of operations, business strategy and financial needs, including the ability of Global Cannabis Applications to generate cash flow from operations and obtain necessary financing on acceptable terms, general economic, financial market, regulatory and political conditions in which Global Cannabis Applications operates, consumer interest in Global Cannabis Applications products, competitions, anticipated costs, government regulation of Global Cannabis Applications activities and products and in areas of taxation and environmental protection, the timely receipt of any required regulatory approvals, and Global Cannabis Applications ability to obtain qualified staff, equipment and services in a timely and cost efficient manner. While Global Cannabis Applications considers these assumptions to be reasonable, these assumptions are inherently subject to significant uncertainties and contingencies. Additionally, there are known and unknown risk factors which could cause Global Cannabis Applications actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. Known risk factors include, among others, regulatory risks, the lack of a public market for the securities of Global Cannabis Applications, the limited operating history and financial track record of Global Cannabis Applications and the uncertainty as to revenues, reliance on key personnel, product liability, unfavorable publicity, management of growth and the difficulty in forecasting.

Forward Looking Statements

slide-4
SLIDE 4

B l

  • c

k c h a i n r e g t e c h a p p s A . I . u s e r r e g i s t r y D i g i t a l T

  • k

e n s D a t a b a s e s

slide-5
SLIDE 5

CITIZEN GREEN TECHNOLOGIES

Overview

In the multibillion-dollar global medical cannabis markets, there is a noticeable lack of regulatory approved medical cannabis products beyond its basic leaf form. The regulatory process to approve cannabis products is slow and inefficient, and it takes substantial time to generate data for product approvals through clinical studies. With over forty-two (42) governments globally moving forward with the legalization of medical cannabis, there is a need and an opportunity to fill the medical cannabis data void using advanced technology. We present the GCAC's Citizen Green Technology Platform. Our leading-edge data platform pre-qualifies candidates for clinical studies and adds to the streamlining of the approval process. The Citizen Green platform is the world's first end-to-end - from seed to sale to patient to regulator - medical cannabis data solution. It uses 6 core technologies: mobile applications, artificial intelligence, Reg Tech, smart databases, blockchain and digital reward tokens, all designed to speed the process of quality data and provide better qualified candidates for clinical studies. As our community grows and the database builds, the platform gathers 'deep learnings' from all Data points and becomes more efficient with the prospect of delivering premium data to the industry, and prequalified applicants for clinical studies.

slide-6
SLIDE 6

CITIZEN GREEN TECHNOLOGIES

Executive Summary

Opportunity

Legal medical cannabis is a multi-billion dollar global phenomenon. Historical restrictions have created a market with little research, limited products and no real process to get products on the shelf. Significant lack of data and information relating to the benefits medical cannabis. Anecdotal and clinical data can provide a baseline for the approval process of future medical cannabis products. Unique, blue sky opportunity to emerge as the dominant technology brand.

Product

Only technology driven cannabis tech company to

  • ffer an end-to-end data aggregation and user delivery

solution. Citizen Green data solution is powered by mobile apps, artificial intelligence (AI), user registry, proprietary analytics. Incorporating Blockchain - the new technology of trust. Seeded with ten years of medical cannabis research and ‘Pain to Strain' modelling engine. Value chain: patients, doctors, pharmacists, dispensaries, LPs, product manufactures and regulators.

Public Company

Global Cannabis Applications Corp. Leveraging inhouse and acquired IP to develop the first of its kind medical cannabis data solution. +300,000 subscribers that fit the Citizen Green target demographic. Seasoned board, management and advisory team with notable technology, industry and capital markets experience. APP on the Canadian Securities Exchange (CSE)

slide-7
SLIDE 7

CITIZEN GREEN TECHNOLOGIES

Corporate Summary

Vision Mission

Aggregate medical cannabis data, Attract patients, doctors, dispensaries, licensed producers and regulators as partners and customers, Provide superior data to growing market. To be the trusted source for medical cannabis data and information. Build an end-to-end solution, from patient to regulator, using mobile applications, artificial intelligence, smart databases and blockchain to:

Corporate Information

Head Office CSE Exchanges and symbols FSE Vancouver, BC APP 2FA OTCQB Shares issued FUAPF 51,450,000 Recent price Average daily volume Market capitalization $0.12 +450,000 $6,174,000

slide-8
SLIDE 8

CITIZEN GREEN TECHNOLOGIES

Global & Growing Markets

The legal cannabis market is expected to grow to an annual global value of US$55.8 billion in 2025. Grandview Research, February 2017 Medical cannabis legal in 42 global markets. The emerging medical cannabis markets are being slowed by fragmented ecosystem with a lack of clinical study level data, limited standarization for med canna product approvals

Lack of trusted data and info contributes to a lack of medical cannabis product and an inefficient approval process.

“ “

USA – 60 % (190 million) of total population live in 29 states where medical cannabis is legal. Germany - 65 million prospective patients; has authorized medical cannabis for 61 different ailments.

slide-9
SLIDE 9

CITIZEN GREEN TECHNOLOGIES

Opportunity

Unique opportunity to build and end-to-end solution to collect and aggregate valuable user data on medical cannabis consumption and consumer behaviour. Use advanced technology to collect and analyze anecdotal and clinical data to build a broad-based, trusted, clinical study level database. Create trusted, clinical research level information highly valued by licensed producers, product manufacturers health providers and government regulators. Be on the ‘right side of regulators’ globally

Faster, more efficient approval process for safe and trusted cannabis products. Improved outcomes for patients.

“ “

Data Value Chain Multiple Revenue / Fee Streams

  • Retailers
  • Pharmacies
  • Universities
  • Dispensary & Pharmacies
  • Online Retailers
  • Suppliers
  • Labs
  • Governments
slide-10
SLIDE 10

CITIZEN GREEN TECHNOLOGIES

GCAC Trusted Data Value Proposition

Trusted Information

Patients Pharmacies Retailers Medical doctors Gain invaluable information regarding pain to strain correlations. Potential improved outcomes. Learn what their clients like and dislike: product type, delivery system, strains, what is working and not working. Reference guide for dosage/information on medical cannabis. Patient info and reference guide for dosage/information on medical cannabis. Suppliers Universities, labs Licensed producers and product manufacturers use data for research and development. Building new studies based on historical data. Regulators Trusted data to bring product to market quicker and more efficiently.

slide-11
SLIDE 11

CITIZEN GREEN TECHNOLOGIES

The worlds first end-to-end data aggregation and user delivery system for the medical cannabis industry. Advanced technologies capture, refine, and continually build a smarter and more trusted medical cannabis database. Mobile Technology Engaging the medical cannabis community while capturing anecdotal information. Artificial Intelligence Algorithms based on 'deep learning' and predictive analysis

  • f opt-in user data to provide premium data to industry,

including qualified candidates for clinical trials. User Registry Database Organizes and integrates user experience data. Blockchain Immutable and trusted distributed health, data and supply chain ledger. Citizen Green Tokens Digital reward system that creates a loyalty program for participating in the blockchain.

slide-12
SLIDE 12

Our Technology Platform

Our Citizen Green Pain to Strain process is the world’s first truly user driven data model, helping create safer & better medical cannabis products

The Citizen Green data process begins with apps capturing inputs. Citizen Green Blockchain is built on NEM technology, the standard in immutable trusted distributed ledger and secure contract system. App users earn Reward Tokens for sharing their data in the system. Tokens are deposited in an e-wallet, redeemable for CannaProducts in medical cannabis programs globally. This data is added to a user registry with inputs from actual clinical studies. Using predictive analysis, proprietary Artificial Intelligence (A.I.) will filter premium GCAC anecdotal data ready for premium data markets.

CITIZEN GREEN TECHNOLOGIES

slide-13
SLIDE 13

Our Mobile Application Technology

CannaCube App Engine

Database IP powering CG apps with 10+ years of medical cannabis patient history Assists users to specify exact pain points, identify suitable strains, and focus cannabis related web searches

CITIZEN GREEN TECHNOLOGIES

Citizen Green mobile apps capture high level anecdotal info; AI and predictive modeling converts to equivalent clinical study data

“ “

slide-14
SLIDE 14

Our Mobile Application Technology

CannaLife App

Social media platform to build global online communities Proprietary search engine, intuitive posting & asynchronized video chat

CITIZEN GREEN TECHNOLOGIES

slide-15
SLIDE 15

Our Mobile Application Technology

Prescriptii App

Locate information about products that have helped similar symptoms Provide feedback/surveys about experience and effectiveness of products

CITIZEN GREEN TECHNOLOGIES

slide-16
SLIDE 16

Our Artificial Intelligence Technology

AI algorithm & predictive analysis

GCAC AI creates 'base' user profile and tracks mobile app users' behaviour and data AI Predictive analysis prequalifies premium medical cannabis data from contributors GCAC Reg Tech AI reduces audit costs and time for medical cannabis industry GCAC Data to set the standard for industry and become valuable to clinical trials

AI refined output

Significantly reduces time required to complete clinical study surveys. Regulators approve new medical cannabis products much faster. Broader research data sources lead to better outcomes for patients.

slide-17
SLIDE 17

Our User Registry Data Technology

“The Trusted Database”

Smart database with 10+ years of medical cannabis patient history. Holds important user experience data from anecdotal data from the GCAC mobile apps and third party clinical trials. Organizes and integrates all input data.

AI Refined Data

Completes data loop AI refined data added to the historical medical database Used by mobile apps, Pain to Strain model, doctor references, etc.

slide-18
SLIDE 18

Our BlockChain Technology

The Trusted Ecosystem

GCAC Blockchain is a distributed health, data and supply chain ledger managed by a trust-less “peer-to-peer” network. Collects regulated supply chain data: licensed producer, manufacture, researchers, registries, dispensaries, patients, medical professionals. Increases secure data exchanges and allows for much easier and more simple data transfer between entities. CG Blockchain includes a digital reward system in the form

  • f CG Tokens (utility coins) that creates credits for

members of the blockchain.

slide-19
SLIDE 19

Our Digital Reward Tokens

Citizen Green Tokens

Tokens, the basis of a loyalty program, are earned in exchange for shared medical cannabis data through GCAC apps and the user registry. Tokens transacted via E-Wallet. Value of the CG Tokens will grow and be used to reward users, pay for additional databases, facilitate research and development, and advance the technological platform.

slide-20
SLIDE 20

CITIZEN GREEN TECHNOLOGIES

Management & Directors

Brad Moore Alexander Helmel

CEO & Director CFO & Director 20 years of practical business leadership experience with Fortune 500 companies Strong background with internet-based start-up corporations Proven track record restructuring and developing early-stage businesses Holds an MBA from Royal Roads University 12 years experience in the Canadian capital markets Over 20 years within the Information Technology Sector Specializes in developing corporate growth strategies, building senior management teams, and developing corporate assets Intimate knowledge of Internal control strategies and corporate governance guidelines

  • BSc. (Mathematics), Certified

Information Systems Auditor (CISA) 2006 A leading Financial Technolgy Entrepreneur with an extensive background in tech, and delivery Proven track record accelerating disruptive technologies globally Director of Fintechgration, Australia’s first FinTech and RegTech aggregator and Commercialisation accelerator Director of Marketing for Australia’s most trusted Bank’s primary investment vehicle – Homesafe Solutions Chairman of C-Suite Network, home of the world’s most trusted network of C-Suite leaders, and a notable media personality. Prime-time television host of “C-Suite with Jeffrey Hayzlett” and “Executive Perspectives” on C-Suite TV, and business podcast host of “All Business with Jeffrey Hayzlett” on CBS’s

  • n-demand radio network Play.It.

Notable public speaker and the author of three bestselling business books, Think Big, Act Bigger: the Rewards of Being Relentless, Running the Gauntlet and the Mirror Test.

Jason Webb

CEO GCAC Australia

Jeffrey Hayzlett

Director

slide-21
SLIDE 21

CITIZEN GREEN TECHNOLOGIES

Advisors & Consultants

Blaise Blatter Rasool Verjee Adam Miller Simon Sorockyj

Serves as Chief Development Officer of BuddingTech and is the GM of Medical Cannabis Counsel of Australia. Joined GCAC advisory board to assist governmental programs. A serial entrepreneur with experience in technology and telecoms, and a diverse global network. Appointed to the advisory board to assist with blockchain and ICO. Founder of BuddingTech and Medical Cannabis Counsel of Australia. Appointed to the board of directors of GCAC Australia. Entrepreneurial tech lawyer with over 20yrs of experience in mobile apps, fintech, global payment systems and blockchain delivery. Will assist with the plan and design of ICO on token based loyalty program. Advisory Advisory Regulatory Expert ICO Expert

Satya Sain Scott Walker

Entrepreneur with around 12 years of experience in technology and mobile product development. Joined GCAC to lead mobile project development. Co-founder of Cannabis Canada Association, has over 25 years of experience as a lobbyist, contractor and

  • consultant. Joined GCAC as special advisor.

Product Development Senior Mgmt. Consultant

slide-22
SLIDE 22

CITIZEN GREEN TECHNOLOGIES

Milestones

Australia Launch

3Q 2017 GCAC Australia 4Q 2017 Citizen Green Apps

650K

2Q 2018 App users

$1M

4Q 2018 Rev/Month

Global

1Q 2019 Launch in all medical jurisdictions

1.4M

2Q 2019 App users

slide-23
SLIDE 23

CITIZEN GREEN TECHNOLOGIES

Projected Revenue Growth

slide-24
SLIDE 24

CITIZEN GREEN TECHNOLOGIES

Capital Structure

Fully Diluted Share Structure

Issued and outstanding Options Warrants ($0.05-$0.10) Fully diluted 51,450,009 13,528,591 3,560,000 68,538,600

slide-25
SLIDE 25

CITIZEN GREEN TECHNOLOGIES

Investment Highlights

Strong business drivers:

  • multi-billion-dollar market phenomenon,
  • total lack of trusted cannabis related information.

Citizen Green solution to become most trusted source for “all things cannabis”. Patented and proprietary blockchain, mobile app and artificial intelligence intellectual property. Revenue and user growth achievable from numerous sources. Prescriptii and CannaLife apps launching 4Q2017 seeded with existing Fundametal app users. Proprietary specialized database IP “CannaCube” powered by + 10 years of medical cannabis patient data. Excellent capital structure. Strong leadership team committed to growth and shareholder value.

slide-26
SLIDE 26

Thanks for listening!

Feel free to contact us with any questions Suite 830, 1100 Melville Street Vancouver, British Columbia, V6E 4A6 info@cannappscorp.com www.cannappscorp.com